Clinical and proteomic characterization of acute myeloid leukemia with mutated RAS. (Q34638143)

3 August 2017

Clinical and proteomic characterization of acute myeloid leukemia with mutated RAS. (English)

1 reference

3 August 2017

1 reference

acute myeloid leukemia

1 reference

2

Hagop Kantarjian

1 reference

3 August 2017

5

Stefan Faderl

1 reference

3 August 2017

10

Jorge Cortes

1 reference

3 August 2017

11

Farhad Ravandi

1 reference

3 August 2017

4

Gautam Borthakur

1 reference

3 August 2017

9

Sherry Pierce

1 reference

PubMed ID

22569880

3 August 2017

Guillermo Garcia-Manero

series ordinal

8

object named as

Guillermo Garcia-Manero

1 reference

3 August 2017

1

Tapan M Kadia

1 reference

3 August 2017

3

Steven Kornblau

1 reference

3 August 2017

7

Raja Luthra

1 reference

3 August 2017

Emil J Freireich

6

1 reference

PubMed ID

22569880

3 August 2017

language of work or name

English

0 references

publication date

8 May 2012

1 reference

3 August 2017

1 reference

3 August 2017

118

1 reference

3 August 2017

22

1 reference

3 August 2017

5550-5559

1 reference

Personalized medicine in non-small-cell lung cancer: is KRAS a useful marker in selecting patients for epidermal growth factor receptor-targeted therapy?

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416961

Implications for KRAS status and EGFR-targeted therapies in metastatic CRC.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416961

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416961

Variable slope normalization of reverse phase protein arrays

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416961

High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416961

Functional proteomic profiling of AML predicts response and survival

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416961

Deregulation of signaling pathways in acute myeloid leukemia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416961

Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416961

Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416961

Implications of NRAS mutations in AML: a study of 2502 patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416961

RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416961

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416961

Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416961

Targeting RAS signalling pathways in cancer therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416961

RAS and leukemia: from basic mechanisms to gene-directed therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416961

N-ras mutations are associated with poor prognosis and increased risk of leukemia in myelodysplastic syndrome

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416961

RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416961

ras oncogenes in human cancer: a review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416961

N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significance.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416961

Activation of the RAS pathway is predictive for a chemosensitive phenotype of acute myelogenous leukemia blasts

7 July 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27596

FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27596

N-ras gene point mutations in Brazilian acute myelogenous leukemia patients correlate with a poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27596

RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27596

Immunohistochemical signal amplification by catalyzed reporter deposition and its application in double immunostaining.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27596

Non-parametric quantification of protein lysate arrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27596

FLT-3 aberrations in acute promyelocytic leukaemia: clinicopathological associations and prognostic impact.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27596

Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27596

Incidence and prognostic value of FLT3 internal tandem duplication and D835 mutations in acute myeloid leukemia

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416961

Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416961

Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia

26 October 2018

1 reference

12 December 2020

Ras oncogene-induced sensitization to 1-beta-D-arabinofuranosylcytosine

1 reference

12 December 2020

Mutations in N-ras predominate in acute myeloid leukemia

1 reference

12 December 2020

The incidence and prognostic significance of mutations in codon 13 of the N-ras gene in acute myeloid leukemia

1 reference

12 December 2020

Enhanced sensitivity to 1-beta-D-arabinofuranosylcytosine and topoisomerase II inhibitors in tumor cell lines harboring activated ras oncogenes

1 reference

12 December 2020

Identifiers

DOI

10.1002/CNCR.27596

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

PubMed ID

22569880